Table 1 Patient demographics and baseline characteristics of treated patients
Characteristic | Patients (n = 22) |
|---|---|
Age, median (min, max), years | 53.5 (37.0, 69.0) |
Gender | |
Female | 11 (50.0) |
Male | 11 (50.0) |
ECOG performance status score, n (%) | |
0 | 6 (27.3) |
1 | 13 (59.1) |
2 | 3 (13.6) |
Corticosteroid therapy at study entry, n (%) | |
Yes | 12 (54.5) |
No | 10 (45.5) |
Prior chemotherapy regimens, n (%) | |
1 | 13 (59.1) |
2 | 7 (31.8) |
3 | 2 (9.1) |
Prior bevacizumab treatment | |
Yes | 5 (22.7) |
No | 17 (77.3) |
